Aptose Biosciences Market Cap

Aptose Biosciences has a market cap or net worth of 18.65 million as of July 2, 2024.

Market Cap

18.65M

Enterprise Value

7.16M

Revenue

n/a

Ranking

n/a

PE Ratio

n/a

Stock Price

1.03

Market Cap Chart

Since May 31, 1998, Aptose Biosciences's market cap has decreased from 33.38M to 18.65M, a decrease of -44.12%. That is a compound annual growth rate of -2.20%.

Market Cap History

Date	Market Cap	% Change
Jul 2, 2024	18.65M	-20.40%
Dec 31, 2023	23.43M	-97.86%
Dec 31, 2022	1.09B	553.58%
Dec 31, 2021	167.36M	-66.06%
Dec 31, 2020	493.13M	26.57%
Dec 31, 2019	389.62M	345.87%
Dec 31, 2018	87.38M	28.75%
Dec 31, 2017	67.87M	188.26%
Dec 31, 2016	23.54M	-44.62%
Dec 31, 2015	42.52M	45,090.82%
Dec 31, 2014	94.08K	-99.74%
May 31, 2014	35.65M	189.59%
May 31, 2013	12.31M	17.24%
May 31, 2012	10.50M	-17.20%
May 31, 2011	12.68M	-51.45%
May 31, 2010	26.12M	20.11%
May 31, 2009	21.75M	-51.22%
May 31, 2008	44.58M	-32.14%
May 31, 2007	65.69M	-13.27%
May 31, 2006	75.74M	-43.36%
May 31, 2005	133.74M	-7.98%
May 31, 2004	145.34M	-20.61%
May 31, 2003	183.07M	89.25%
May 31, 2002	96.73M	-52.81%
May 31, 2001	204.99M	4.59%

View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Bausch + Lomb Corporation	6.95B
Bausch Health Companies Inc.	3.50B
Tilray Brands, Inc.	1.87B
WELL Health Technologies Corp.	1.16B
Sienna Senior Living Inc.	1.04B
Canopy Growth Corporation	673.59M
Extendicare Inc.	603.70M
Knight Therapeutics Inc.	574.80M

Market Cap Rankings